360 related articles for article (PubMed ID: 21192081)
1. Characterization of retinal function and glial cell response in a mouse model of oxygen-induced retinopathy.
Vessey KA; Wilkinson-Berka JL; Fletcher EL
J Comp Neurol; 2011 Feb; 519(3):506-27. PubMed ID: 21192081
[TBL] [Abstract][Full Text] [Related]
2. The vasoneuronal effects of AT1 receptor blockade in a rat model of retinopathy of prematurity.
Hatzopoulos KM; Vessey KA; Wilkinson-Berka JL; Fletcher EL
Invest Ophthalmol Vis Sci; 2014 Jun; 55(6):3957-70. PubMed ID: 24894399
[TBL] [Abstract][Full Text] [Related]
3. Neuronal and glial cell changes are determined by retinal vascularization in retinopathy of prematurity.
Downie LE; Pianta MJ; Vingrys AJ; Wilkinson-Berka JL; Fletcher EL
J Comp Neurol; 2007 Oct; 504(4):404-17. PubMed ID: 17663451
[TBL] [Abstract][Full Text] [Related]
4. Effects of sustained hyperoxia on revascularization in experimental retinopathy of prematurity.
Gu X; Samuel S; El-Shabrawey M; Caldwell RB; Bartoli M; Marcus DM; Brooks SE
Invest Ophthalmol Vis Sci; 2002 Feb; 43(2):496-502. PubMed ID: 11818396
[TBL] [Abstract][Full Text] [Related]
5. Visual cycle modulation in neurovascular retinopathy.
Akula JD; Hansen RM; Tzekov R; Favazza TL; Vyhovsky TC; Benador IY; Mocko JA; McGee D; Kubota R; Fulton AB
Exp Eye Res; 2010 Aug; 91(2):153-61. PubMed ID: 20430026
[TBL] [Abstract][Full Text] [Related]
6. Localization of adenosine A2a receptor in retinal development and oxygen-induced retinopathy.
Taomoto M; McLeod DS; Merges C; Lutty GA
Invest Ophthalmol Vis Sci; 2000 Jan; 41(1):230-43. PubMed ID: 10634625
[TBL] [Abstract][Full Text] [Related]
7. Localization of VEGF receptor-2 (KDR/Flk-1) and effects of blocking it in oxygen-induced retinopathy.
McLeod DS; Taomoto M; Cao J; Zhu Z; Witte L; Lutty GA
Invest Ophthalmol Vis Sci; 2002 Feb; 43(2):474-82. PubMed ID: 11818393
[TBL] [Abstract][Full Text] [Related]
8. Neuronal-driven angiogenesis: role of NGF in retinal neovascularization in an oxygen-induced retinopathy model.
Liu X; Wang D; Liu Y; Luo Y; Ma W; Xiao W; Yu Q
Invest Ophthalmol Vis Sci; 2010 Jul; 51(7):3749-57. PubMed ID: 20207957
[TBL] [Abstract][Full Text] [Related]
9. Soluble forms of EphrinB2 and EphB4 reduce retinal neovascularization in a model of proliferative retinopathy.
Zamora DO; Davies MH; Planck SR; Rosenbaum JT; Powers MR
Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):2175-82. PubMed ID: 15914639
[TBL] [Abstract][Full Text] [Related]
10. Expression of pro- and anti-angiogenic isoforms of VEGF in the mouse model of oxygen-induced retinopathy.
Zhao M; Shi X; Liang J; Miao Y; Xie W; Zhang Y; Li X
Exp Eye Res; 2011 Dec; 93(6):921-6. PubMed ID: 22067127
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous assessment of aberrant retinal vascularization, thickness, and function in an in vivo mouse oxygen-induced retinopathy model.
Mezu-Ndubuisi OJ; Adams T; Taylor LK; Nwaba A; Eickhoff J
Eye (Lond); 2019 Mar; 33(3):363-373. PubMed ID: 30209267
[TBL] [Abstract][Full Text] [Related]
12. Differences between rat strains in models of retinopathy of prematurity.
Floyd BN; Leske DA; Wren SM; Mookadam M; Fautsch MP; Holmes JM
Mol Vis; 2005 Jul; 11():524-30. PubMed ID: 16052168
[TBL] [Abstract][Full Text] [Related]
13. Adenosine A1 Receptors Selectively Modulate Oxygen-Induced Retinopathy at the Hyperoxic and Hypoxic Phases by Distinct Cellular Mechanisms.
Zhang S; Li H; Li B; Zhong D; Gu X; Tang L; Wang Y; Wang C; Zhou R; Li Y; He Y; Chen M; Huo Y; Liu XL; Chen JF
Invest Ophthalmol Vis Sci; 2015 Dec; 56(13):8108-19. PubMed ID: 26720463
[TBL] [Abstract][Full Text] [Related]
14. T2-TrpRS inhibits preretinal neovascularization and enhances physiological vascular regrowth in OIR as assessed by a new method of quantification.
Banin E; Dorrell MI; Aguilar E; Ritter MR; Aderman CM; Smith AC; Friedlander J; Friedlander M
Invest Ophthalmol Vis Sci; 2006 May; 47(5):2125-34. PubMed ID: 16639024
[TBL] [Abstract][Full Text] [Related]
15. 5' nucleotidase and adenosine during retinal vasculogenesis and oxygen-induced retinopathy.
Lutty GA; Merges C; McLeod DS
Invest Ophthalmol Vis Sci; 2000 Jan; 41(1):218-29. PubMed ID: 10634624
[TBL] [Abstract][Full Text] [Related]
16. AT1 receptor inhibition prevents astrocyte degeneration and restores vascular growth in oxygen-induced retinopathy.
Downie LE; Pianta MJ; Vingrys AJ; Wilkinson-Berka JL; Fletcher EL
Glia; 2008 Aug; 56(10):1076-90. PubMed ID: 18442090
[TBL] [Abstract][Full Text] [Related]
17. Long-term evaluation of retinal morphology and function in a mouse model of oxygen-induced retinopathy.
Mezu-Ndubuisi OJ; Macke EL; Kalavacherla R; Nwaba AA; Suscha A; Zaitoun IS; Ikeda A; Sheibani N
Mol Vis; 2020; 26():257-276. PubMed ID: 32256029
[TBL] [Abstract][Full Text] [Related]
18. CEACAM1 confers resistance toward oxygen-induced vessel damage in a mouse model of retinopathy of prematurity.
Ludewig P; Flachsbarth K; Wegscheid C; Tiegs G; Richard G; Wagener C; Bartsch U; Horst AK
Invest Ophthalmol Vis Sci; 2014 Nov; 55(12):7950-60. PubMed ID: 25406283
[TBL] [Abstract][Full Text] [Related]
19. Regression of retinopathy by squalamine in a mouse model.
Higgins RD; Yan Y; Geng Y; Zasloff M; Williams JI
Pediatr Res; 2004 Jul; 56(1):144-9. PubMed ID: 15128931
[TBL] [Abstract][Full Text] [Related]
20. Aldose reductase deficiency reduced vascular changes in neonatal mouse retina in oxygen-induced retinopathy.
Fu ZJ; Li SY; Kociok N; Wong D; Chung SK; Lo AC
Invest Ophthalmol Vis Sci; 2012 Aug; 53(9):5698-712. PubMed ID: 22836764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
